.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Chubb
Medtronic
Cerilliant
Daiichi Sankyo
Fish and Richardson
UBS
US Department of Justice
Dow
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062483

« Back to Dashboard
NDA 062483 describes GRIFULVIN V, which is a drug marketed by J And J, Johnson And Johnson, and Valeant Luxembourg, and is included in four NDAs. It is available from one supplier. Additional details are available on the GRIFULVIN V profile page.

The generic ingredient in GRIFULVIN V is griseofulvin, microsize. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.

Summary for NDA: 062483

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 062483

Suppliers and Packaging for NDA: 062483

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GRIFULVIN V
griseofulvin, microsize
SUSPENSION;ORAL 062483 ANDA Physicians Total Care, Inc. 54868-5234 54868-5234-0 120 mL in 1 BOTTLE (54868-5234-0)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 26, 1984TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Accenture
Mallinckrodt
Deloitte
Colorcon
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot